Overview

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This study will describe the long-term safety and effectiveness, treatment patterns,and patient reported quality of life associated with ranibizumab treatment in routine clinical practice for all approved indication included in the local product label.
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Ranibizumab